Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenue, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Net revenue	$ 3,244,857	$ 3,260,975	$ 3,200,177
Costs and expenses:
Cost, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Cost of net revenue	$ 2,635,658	$ 2,579,882	$ 2,576,110
General and administrative expenses	382,293	359,238	334,594
Depreciation and amortization, excluding patient equipment depreciation	40,640	45,045	57,087
Goodwill impairment (note 7)	127,995	13,078	830,787
Total costs and expenses	3,186,586	2,997,243	3,798,578
Gain on sale of businesses (note 4)	(32,602)	0	0
Operating income (loss)	90,873	263,732	(598,401)
Interest expense, net	105,753	126,668	130,299
Loss on extinguishment of debt	0	2,273	0
Change in fair value of warrant liability (note 13)	0	(4,021)	(34,482)
Other loss, net	274	2,793	29,566
(Loss) income before income taxes	(15,154)	136,019	(723,784)
Income tax expense (benefit)	50,884	41,239	(49,004)
Net (loss) income	(66,038)	94,780	(674,780)
Income attributable to noncontrolling interest	4,756	4,358	4,115
Net (loss) income attributable to AdaptHealth Corp.	$ (70,794)	$ 90,422	$ (678,895)
Weighted average common shares outstanding - basic (in shares)	135,146	133,756	134,156
Weighted average common shares outstanding - diluted (in shares)	135,146	135,531	134,418
Basic net (loss) income per share (in dollars per share)	$ (0.52)	$ 0.62	$ (5.06)
Diluted net (loss) income per share (in dollars per share)	$ (0.52)	$ 0.61	$ (5.31)